🔗 Share this article

This year's prestigious award in Physiology or Medicine has been granted for revolutionary findings that illuminate how the body's defense network attacks dangerous pathogens while protecting the body's own cells.

Three esteemed scientists—Japan's Prof. Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—share this accolade.

Their work uncovered unique "security guards" within the immune system that remove rogue defense cells that could harming the organism.

These findings are now paving the way for innovative treatments for immune disorders and malignancies.

The laureates will divide a prize fund valued at 11m Swedish kronor.

Crucial Findings

"The work has been decisive for understanding how the body's defenses operates and why we don't all develop severe autoimmune diseases," stated the chair of the award panel.

This trio's studies explain a fundamental question: How does the defense system defend us from numerous infections while keeping our healthy cells unharmed?

The immune system uses immune cells that search for indicators of disease, including pathogens and germs it has never encountered.

Such defenders utilize sensors—known as recognition units—that are produced randomly in a vast number of variations.

That provides the defense network the capacity to combat a broad range of threats, but the unpredictability of the process inevitably produces immune cells that may attack the host.

Protectors of the Immune System

Scientists earlier knew that some of these problematic defense cells were eliminated in the immune organ—the site where white blood cells develop.

This year's Nobel Prize recognizes the identification of regulatory T-cells—described as the body's "peacekeepers"—which patrol the body to neutralize other defenders that attack the healthy cells.

It is known that this process fails in autoimmune diseases such as type-1 diabetes, MS, and rheumatoid arthritis.

A prize committee stated, "These findings have laid the foundation for a novel area of research and accelerated the development of new therapies, for instance for tumors and immune disorders."

In cancer, T-regs block the body from attacking the growth, so studies are focused on lowering their quantity.

In autoimmune diseases, trials are exploring boosting regulatory T-cells so the organism is no longer under attack. A similar approach could also be useful in minimizing the chances of transplanted organ failure.

Pioneering Studies

Professor Shimon Sakaguchi, from a Japanese institution, conducted tests on rodents that had their thymus removed, leading to autoimmune disease.

He showed that introducing immune cells from healthy mice could prevent the illness—suggesting there was a system for blocking immune cells from harming the body.

Mary Brunkow, from the Institute for Systems Biology in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an genetic autoimmune disease in mice and people that resulted in the identification of a gene vital for the way T-regs operate.

"The groundbreaking research has uncovered how the immune system is kept in check by T-reg cells, stopping it from mistakenly attacking the body's own tissues," commented a prominent biological science specialist.

"This research is a remarkable illustration of how fundamental physiological research can have far-reaching implications for public health."